跳至主要内容
临床试验/JPRN-UMIN000003919
JPRN-UMIN000003919已完成4 期

Efficacy of combination therapy of angiotensin II receptor blocker (ARB) and diuretic in hypertensive patients with chronic kidney disease (CKD) - Combined ARB And Thiazide in CKD Treatment Study

Kyoto University Hospital0 个研究点目标入组 30 人开始时间: 2010年7月16日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with uncontrolled hypertension (DBP >= 110mmHg) 2) Patients with malignant hypertension 3) Patients with uncontrolled diabetes (HbA1c >= 8.0%) and patients under insulin treatment 4) Patients who have stroke, AMI and/or critical vascular complications that required hospitalization within 6 months prior to the intervention 5) Patients with liver dysfunction [GPT(ALT) over three times the normal value] 6) Patients with critical renal failure (serum creatinine >= 3.0 mg/dL) 7) Patients with a previous history of gout attack or uncontrolled hyperuricemia (UA >= 9.0mg/dL) 8) Pregnant or breast feeding female patients, including one trying to conceive pregnancy during the planned study period 9) Patients with uncontrolled arrhythmia 10) Patients with cardiac insufficiency (NYHA grade III or IV) 11) Patients with a history of hypersensitivity to ingredients of losartan 12) Patients with a history of hypersensitivity to thiazide or thiazide-like diuretics 13) Patients who are considered not eligible for the study by the attending doctor due to medical reasons

研究者

相似试验

Efficacy of combination therapy of angiotensin II... | 临床试验